TAK-935/OV935

Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
CP Wire
Wed, 07/18/18 - 10:00 am
Takeda
Ovid Therapeutics
TAK-935/OV935